14 May 2026 - Apotex today announced the commercial launch of Apo‑Semaglutide Injection – a generic equivalent of Ozempic. 

With initial inventory now available and shipping to wholesalers, Apo‑Semaglutide Injection will be on pharmacy shelves across Canada within the coming weeks, giving patients and their health care providers access to high quality, affordable alternatives aligned to all available brand equivalent formats.

Read Apotex press release